Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 1923-1929, December 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhuyan, B. K.
Right arrow Articles by Li, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhuyan, B. K.
Right arrow Articles by Li, L. H.

Biological and Biochemical Differences between Tubercidin (7-Deazaadenosine) and Its 5'-Phosphate Methyl Ester1

Bijoy K. Bhuyan, Gary L. Neil, Charles G. Smith2, Elma J. Olin and L. H. Li

Research Laboratories, The Upjohn Company, Kalamazoo, Michigan 49001

On a molar basis, tubercidin (Tu) was about 20 times more cytotoxic than the methyl ester of tubercidin 5'-phosphate (MepTu) when KB cells were exposed to the drugs for 1 hr. In contrast, the drugs were about equitoxic when they were in contact with cells for 72 hr. The same relationship was seen when the inhibition of DNA synthesis by the drugs was compared after short- and long-term contact of the cells with the drugs.

The delayed cytotoxicity of MepTu toward mammalian cells was mostly due to the slow rate of hydrolysis of MepTu to Tu. The serum in the medium was responsible for most of the hydrolysis while intact KB cells and L1210 cells themselves had less hydrolytic activity.

The rates of hydrolysis of MepTu by serum of different animal species are described. Human serum had low hydrolytic capacity while mouse serum was highly active. The amount of MepTu taken up by blood cells was proportional to the percentage of hydrolysis of MepTu to Tu.

Both Tu and MepTu (after hydrolysis to Tu) were present in the acid-soluble pool as Tu phosphates and were incorporated into RNA and to a much lesser extent into DNA.

1 This study was supported in part by Contract PH43-68-1023 with Chemotherapy, National Cancer Institute, NIH, Bethesda, Md. 20014.

2 Present address: The Squibb Institute for Medical Research, New Brunswick, N. J. 08903.

Received 11/ 2/70. Accepted 7/13/71.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.